declatasvir

High Stakes Intrigue In Hep C: Bristol-Myers Vs. Gilead
Seeking Alpha
Thu, 01/23/14 - 08:23 am
hepatitis C
Gilead Sciences
Bristol-Myers Squibb
Sovaldi
declatasvir
Bristol-Myers Ties Hepatitis C Success to Gilead’s Pill
Bloomberg
Tue, 01/14/14 - 09:15 am
hepatitis C
Gilead Sciences
Bristol-Myers Squibb
Sovaldi
declatasvir
Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
Bloomberg
Mon, 04/29/13 - 10:26 am
Gilead
Bristol-Myers Squibb
hepatitis C
declatasvir
sofosbuvir
Bristol-Myers Hepatitis C Combo Therapy Shows Promise
Bloomberg
Tue, 11/13/12 - 11:11 am
hepatitis C
Bristol-Myers Squibb
BMS-791325
asunaprevir
declatasvir
Bristol Hep C Trial Change Has Big Implications
Pharmalot
Wed, 06/20/12 - 12:31 pm
hepatitis C
Bristol-Myers Squibb
clinical trials
Gilead
NS5A Inhibitors
declatasvir